Together Redefined: Discover Our Rebranding Trailer. Watch Now!
yaveon favicon bildmarke
Icon weiße Lupe

Audit trail & electronic signatures: Why ERP is indispensable for approval processes in pharma, medtech and biotech

Published Aug 14, 2025
Hand interacting with digital interface showing a glowing checkmark.

Summary:
Our article explains why ERP is indispensable for approval processes in the pharmaceutical, medtech and biotech industries and how you can implement them. 

In this article:

Safety, quality, traceability: in the pharmaceutical industry, every step has to be right and documented seamlessly and audit-proof. The requirements of FDA 21 CFR Part 11 and ISO 13485 are strict and leave no room for maneuver. They demand control, transparency and security - supported by a system. The solution: a validated ERP system including an audit trail and electronic signatures. 

In regulated industries, documentation decides everything

In the pharmaceutical, medtech and biotech industries, documented approvals determine product approval, quality and company safety. This means that every step must be verifiable, tamper-proof and traceable, as well as auditable and legally compliant. 

Audit trails and electronic signatures are not optional, but mandatory. Regulations such as FDA 21 CFR Part 11, EU GMP Annex 11 or ISO 13485 leave no room for maneuver: they require digital control, traceable data flows and validated systems. 

The solution: a specialized ERP system that integrates audit trails and electronic signatures and supports validation - for compliance, process reliability and trust. 

Strict specifications: What FDA, Annex 11 & ISO 13485 specifically require

FDA 21 CFR Part 11 (Pharma, Biotech)

This US regulation governs the requirements for electronic signatures and digital documentation in regulated environments: 

  • Legally binding electronic signatures
  • Audit trails with timestamp, user & reason for change
  • Protection mechanisms to ensure data integrity
  • Validation capability of computerized systems 

EU GMP Annex 11 (pharma, biotech) 

Annex 11 supplements the EU GMP guidelines specifically for IT-supported systems - with a focus on: 

  • System validation, GAMP 5 can be used as a guide here
  • Audit trails and user rights
  • Data integrity and archiving
  • Life cycle management for software 

ISO 13485 (MedTech) 

The international standard for quality management systems in medical technology places particular emphasis on 

  • Seamless documentation of all quality-relevant processes
  • Traceability over the entire product life cycle
  • Effective CAPA measures
  • Validation of software that is part of the QMS 

The status quo: manual processes and audit risks

However, many companies in the pharmaceutical industry are still a long way from meeting the requirements as they continue to work in an analog way. This approach often leads to enormous effort and limited clarity, which is increasingly viewed critically by supervisory authorities. 

Many deliberately opt for the analog approach due to the lack of reliable digital systems. However, in an industry characterized by precise requirements and strict regulations, this approach is becoming increasingly difficult to maintain. 

Manual errors 

Typing errors, duplicate entries and lost or incorrectly filed documents are expensive, time-consuming and can quickly become a problem in an audit. 

Data silos 

If quality, production and release data are distributed across different systems, it is easy to lose track of everything. Traceability? Not a chance.

Slow, non-transparent processes 

Who released what and when? Without an audit trail, this remains unclear. This is particularly risky with multi-stage approvals.

No audit capability

Without a validated ERP system, there is a lack of audit-proof evidence. As this is crucial for audits, you will not be able to pass them, you will not receive any approvals and you will lose success on the market.

The solution: audit trails and electronic signatures in the ERP industry solution

A specialized ERP industry solution not only manages data, but also controls pharmaceutical processes intelligently, transparently and traceably. It ensures seamless traceability, automated workflows, secure electronic signatures and end-to-end documentation - validated, compliant with FDA 21 CFR Part 11 and developed strictly in accordance with GAMP 5.  

Mockup of Yaveon Papers

Audit-ready, digital, efficient – with the right ERP!

Our brochure shows how Yaveon 365, the ERP solution for the process industry, helps you design approval processes in pharma, medtech, and biotech that are secure and compliant.

The most important functions:

Batch management
Traceability of substances, intermediate and end products in real time, batch-accurate and seamless.

Audit trail
Every relevant action is documented: User name, time stamp, action, reason for change are stored completely, unalterably and audit-proof.

Electronic signatures
Releases and approvals are digital, with secure authentication and clear assignment.

User & rights management
Only authorized persons have access to sensitive data and functions thanks to the role and authorization concept.

Quality controls
From incoming goods to the end product: flawless quality is a basic requirement for safe products. Test plans, limit values, deviations and measures are therefore managed digitally.

Long-term archiving & data integrity
The industry ERP stores audit trails, release data and quality certificates securely and permanently. The integrity of the data remains legally compliant for years and can be retrieved at any time.

Validation & GAMP 5 compliance
To ensure that you reliably meet the strict requirements, a suitable ERP industry solution is developed in accordance with GAMP5 best practices and is suitable for computer system validation.

Scenario from practice: Digital release with full traceability

The theory is one thing. But what does the practice look like? Here's an example. 

The company's Qualified Person releases a batch. The system documents automatically: 

  • Time of release
  • User name and role
  • Check results and decision
  • Electronic signature with proof of authentication
  • Comment with reason for change 

Result: The release is traceable, secure, auditable and directly linked to the product batch. No paper, no doubt, no gaps. 

No progress without compliance? No success without a system.

In the pharmaceutical, medical technology and biotechnology industries, there is no regulatory future without digital traceability. Audit trails and electronic signatures are not just requirements, they are the digital backbone of your approval processes. 

With the right ERP industry solution, you can master audits with confidence, speed up processes and ensure the long-term quality of your products. 

Learn how our solution can make you audit-ready, efficient and future-proof!  

Autor Stefan Klammler

Questions for our expert Stefan Klammler?

Contact our team and we will get back to you.

Trends, tips & events:
current insights

Change control in the pharmaceutical industry Change control in the pharmaceutical industry – Beitrag öffnen
Change control in the pharmaceutical industry

Safe products are essential for the pharmaceutical industry. What is the role of change control in this? We explain.

Success story: Hameln Pharma Success story: Hameln Pharma – Beitrag öffnen
Success story: Hameln Pharma

Read how hameln pharma connects an external warehouse largely with a standard interface and saves time through automated processes.

Success story: Midas Pharma Success story: Midas Pharma – Beitrag öffnen
Success story: Midas Pharma

Read the report to find out how Midas uses a direct warehouse connection to the external logistics provider and processes orders automatically.

Yaveon Favicon
More than 750 companies trust Yaveon as their ERP partner of choice
Yaveon Favicon
© 2025 Yaveon. All rights reserved.
cross